Abstract
We report here the whole-genome sequence of the USA300 strain of methicillin-resistant Staphylococcus aureus (MRSA), designated ATCC BAA-1680, and commonly referred to as community-associated MRSA (CA-MRSA). This clinical MRSA isolate is commercially available from the American Type Culture Collection (ATCC) and is widely utilized as a control strain for research applications and clinical diagnosis. The isolate was propagated in ATCC medium 18, tryptic soy agar, and has been utilized as a model S. aureus strain in several studies, including MRSA genetic analysis after irradiation with 470-nm blue light.
GENOME ANNOUNCEMENT
Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium responsible for a variety of clinical manifestations and increasing cases of community-acquired infections (1). MRSA infection accounts for 44% of all hospital associated infections in the United States (2), and as many as 92% of persons hospitalized for MRSA have community-acquired (CA-MRSA), typically from the USA300 strain.
Whole-genome characterization has been performed for a number MRSA clinical and reference S. aureus strains (3, 4). This is the first report of a whole-genome sequence for an American Type Culture Collection (ATCC) strain designated ATCC BAA-1680 (referred to here as reference strains 25b and 26b). Additionally, we report whole-genome sequences containing synonymous and nonsynonymous nucleotide mutations of four MRSA ATCC BAA-1680 isolates, 27b, 29b, 31b, and 33b, after exposure to blue light (at 470 nm) irradiation at 3, 55, 110, and 110 J/cm2, respectively.
Total genomic DNA (gDNA) from culture grown MRSA reference isolates (25b and 26b) was obtained using the PrimeXtact total genomic extraction spin kit, as described earlier (5). For next-generation sequencing (NGS) library preparation, approximately 5 ng of input gDNA was processed using the Nextera XT sample prep kit (Illumina, San Diego, CA, USA). MiSeq NGS was performed according to the manufacturer’s instructions (Illumina) using the MiSeq reagent kit (version 3) with 600 cycles. Following fragmentation, end preparation, and sample tagging, the sequencer produced 6.2 and 6.3 million paired reads for ATCC BAA-1680 reference strains designated 25b and 26b, respectively, yielding appreciable coverage of ~200× for both strains. Assembly was performed using LaserGene DNAStar N-Gen version 12.1 (LaserGene, Inc., Madison, WI, USA). The strain 25b assembly resulted in a single contig totaling 2.3 billion bases with 6.2 million total reads (average read length, 376 bases), while the strain 26b assembly resulted in a single contig totaling 2.2 billion bases with 6.3 million total reads (average read length, 352 bases). Annotations were performed by the NCBI Prokaryotic Genomes Annotation Pipeline. The MRSA chromosome of reference strain 25b (accession no. CP010299) contains 2,937 genes, 2,845 coding sequences (CDSs), 16 rRNAs, and 52 tRNAs, while the chromosome of strain 26b (accession no. CP010298) contains 2,938 genes, 2,846 CDSs, 16 rRNAs, and 52 tRNAs.
The ATCC BAA-1680 strains 25b and 26b were used as controls for a larger study to investigate possible genetic effects underlying the antimicrobial effects of 470-nm blue light on MRSA and any genetic differences between irradiated and control MRSA strains upon whole-genome sequence comparisons. The effective antimicrobial properties that blue light irradiation has on MRSA may be attributed to mutational changes identified by whole-genome analysis and may facilitate a better understanding of the antimicrobial effect of blue light, an alternative armamentarium for combating MRSA infections (6).
Nucleotide sequence accession numbers.
The whole-genome sequences of MRSA ATCC BAA-1680 control strains 25b and 26b were deposited in the DDBJ/EMBL/GenBank databases under the accession numbers CP010299 and CP010298, respectively. The whole-genome sequences of four MRSA ATCC BAA-1680 blue light-treated strains were deposited in the DDBJ/EMBL/GenBank databases under the following accession numbers: CP010300 (strain 27b [at 3 J/cm2]), CP010295 (strain 29b [at 55 J/cm2]), CP010296 (strain 31b [at 110 J/cm2]), and CP010297 (strain 33b [at 110 J/cm2]).
ACKNOWLEDGMENT
This work was funded by the University of Wisconsin-Milwaukee College of Health Sciences (CHS) Stimulus for Extramural Enhancement & Development (SEED) Program subcontracted to the Milwaukee Health Department Laboratory.
Footnotes
Citation Daum LT, Bumah VV, Masson-Meyers DS, Khubbar M, Rodriguez JD, Fischer GW, Enwemeka CS, Gradus S, Bhattacharyya S. 2015. Whole-genome sequence for methicillin-resistant Staphylococcus aureus strain ATCC BAA-1680. Genome Announc 3(2):e00011-15. doi:10.1128/genomeA.00011-15.
REFERENCES
- 1.David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687. doi: 10.1128/CMR.00081-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gould DJ, Moralejo D, Drey N, Chudleigh J. 2008. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev (9):CD005186. doi: 10.1002/14651858.CD005186.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hernandez D, Seidl K, Corvaglia A-R, Bayer AS, Xiong YQ, François P. 2014. Genome sequences of sequence type 45 (ST45) persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia strain 300-169 and ST45 resolving MRSA bacteremia strain 301-188. Genome Announc 2(2):e00174-14. doi: 10.1128/genomeA.00174-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Treangen TJ, Maybank RA, Enke S, Friss MB, Diviak LF, Karaolis DK, Koren S, Ondov B, Phillippy AM, Bergman NH, Rosovitz MJ. 2014. Complete genome sequence of the Quality control strain Staphylococcus aureus subsp. aureus ATCC 25923. Genome Announc 2(6):e01110-14. doi: 10.1128/genomeA.01110-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Daum LT, Peters RP, Fourie BP, Worthy SA, Rodriguez JD, Ismail NA, Omar SV, Fischer GW. Efficient transport of sputum specimens to central laboratories may facilitate TB detection in low resource rural settings. Int J Tuberc Lung Dis, in press. [DOI] [PubMed] [Google Scholar]
- 6.Enwemeka CS. 2013. Antimicrobial blue light: an emerging alternative to antibiotics. Photomed Laser Surg 31:509–511. doi: 10.1089/pho.2013.9871. [DOI] [PubMed] [Google Scholar]